Estrogen‐Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients

Genetics and mechanisms of hepatic cystogenesis

(2018) L.F.M. van de Laarschot et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Clinical management of polycystic liver disease

(2018) René M.M. van Aerts et al.   JOURNAL OF HEPATOLOGY

Lifetime endogenous estrogen exposure and disease severity in female patients with facioscapulohumeral muscular dystrophy

(2018) Karlien Mul et al.   NEUROMUSCULAR DISORDERS

Severity in polycystic liver disease is associated with etiology and female gender; results of the International PLD Registry

(2018) René M.M. van Aerts et al.   LIVER INTERNATIONAL

Impact of liver volume on polycystic liver disease-related symptoms and quality of life

(2017) Myrte K Neijenhuis et al.   United European Gastroenterology Journal

Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial

(2016) Hedwig M.A. D’Agnolo et al.   JOURNAL OF HEPATOLOGY

Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease

(2016) Fouad T. Chebib et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver Disease

(2015) Frederik Temmerman et al.   Clinical Gastroenterology and Hepatology

Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease

(2015) Marie C. Hogan et al.   Clinical Gastroenterology and Hepatology

Creating an effective clinical registry for rare diseases

(2015) Hedwig MA D’Agnolo et al.   United European Gastroenterology Journal

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease

(2015) Hyunsuk Kim et al.   PLoS One

Differences in ovarian hormones in relation to parity and time since last birth

(2014) Emily S. Barrett et al.   FERTILITY AND STERILITY

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data

(2013) F. Temmerman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

(2013) Esther Meijer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Young Women With Polycystic Liver Disease Respond Best to Somatostatin Analogues: A Pooled Analysis of Individual Patient Data

(2013) Tom J.G. Gevers et al.   GASTROENTEROLOGY

Prenatal famine, birthweight, reproductive performance and age at menopause: the Dutch hunger winter families study

(2013) F. Yarde et al.   HUMAN REPRODUCTION

Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume

(2013) Titus F. M. Wijnands et al.   LIVER INTERNATIONAL

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

(2012)   LANCET ONCOLOGY

G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling

(2011) Bengt-Olof Nilsson et al.   BRITISH JOURNAL OF PHARMACOLOGY

Determinants of Maternal Sex Steroids During the First Half of Pregnancy

(2011) Adetunji T. Toriola et al.   OBSTETRICS AND GYNECOLOGY

Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial

(2009) Loes van Keimpema et al.   GASTROENTEROLOGY